Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Business Overview and Strategic Focus
HAE logo

Haemonetics Revenue Climbs 4% to $1.36B on Hospital Surge

HAE10-KFiling Date: 5/21/2025
Haemonetics Corporation
Description

What this story covers

Haemonetics reported $1.36B revenue in fiscal 2025, up 4%, driven by 24% Hospital growth from acquisitions like Attune and OpSens. Plasma and Blood Center dipped amid market challenges and divestitures. Net income rose 43% to $168M, with strong liquidity despite $1.2B debt. Risks include competition, regulations, and international volatility, but trends favor plasma demand and interventional procedures.

Story snapshot

CompanyHaemonetics Corporation
TickerHAE
VariantStandard detailed
Duration13:22
Filing type10-K
PeriodAnnual 2025
IndustryHealthcare & Pharmaceuticals
Accession0000313143-25-000025

Full Story Script

Content not available for this story.

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in